Connection
Nicole Massoll to Gene Silencing
This is a "connection" page, showing publications Nicole Massoll has written about Gene Silencing.
|
|
Connection Strength |
|
|
|
|
|
0.141 |
|
|
|
-
Ai L, Kim WJ, Demircan B, Dyer LM, Bray KJ, Skehan RR, Massoll NA, Brown KD. The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer. Carcinogenesis. 2008 Mar; 29(3):510-8.
Score: 0.074
-
Ai L, Kim WJ, Kim TY, Fields CR, Massoll NA, Robertson KD, Brown KD. Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression. Cancer Res. 2006 Aug 15; 66(16):7899-909.
Score: 0.067